Skip to main content

Advertisement

SpringerLink
Log in

Recommendations of the Schizophrenia Expert Center network for adequate physical activity in real-world schizophrenia (FACE-SZ)

  • Original Paper
  • Published:
European Archives of Psychiatry and Clinical Neuroscience Aims and scope Submit manuscript

Abstract

The World Health Organization (WHO) recommends adults complete 150–300 min per week of moderate physical activity or 75–150 min of vigorous physical activity or an equivalent combination of both, to optimize health. To explore the factors associated with adequate MVPA in stabilized outpatients with schizophrenia. 425 stabilized outpatients were recruited in the national FACE-SZ cohort between 2015 and 2018 were evaluated with the International Physical Activity Questionnaire and a 1-day long standardized battery. We explored in multivariate analyses the clinical and pharmacological factors associated with MVPA (model 1) and the biological factors and patient-reported outcomes (model 2). Overall, only 86 (20.2%) of the 425 participants achieved the recommended MVPA threshold. In model 1, the adequate MVPA group was associated with younger age, mood stabilizers prescription and adherence to treatment, independent of sex, positive and depressive symptoms, first-generation antipsychotics prescription, anxiolytic medication, and akathisia. In model 2, adequate MVPA was associated with better glycemic and lipidic profile and better physical and psychological well-being, self-esteem, sentimental life, and resilience independently of age, sex, and current psychotic severity. The expert centers recommend the importance of promoting promote effective MVPA programs for stabilized patients with schizophrenia. Interventions studies suggest that MVPA may be a useful strategy to maximize physical and psychological well-being and self-esteem and potentially to prevent or manage metabolic disturbances.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bull FC, Al-Ansari SS, Biddle S et al (2020) World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med 54:1451–1462. https://doi.org/10.1136/bjsports-2020-102955

    Article  PubMed  Google Scholar 

  2. Stubbs B, Williams J, Gaughran F, Craig T (2016) How sedentary are people with psychosis? A systematic review and meta-analysis. Schizophr Res 171:103–109. https://doi.org/10.1016/j.schres.2016.01.034

    Article  PubMed  Google Scholar 

  3. Scheewe TW, Jörg F, Takken T et al (2019) Low physical activity and cardiorespiratory fitness in people with schizophrenia: a comparison with matched healthy controls and associations with mental and physical health. Front Psychiatry 10:87. https://doi.org/10.3389/fpsyt.2019.00087

    Article  PubMed  PubMed Central  Google Scholar 

  4. Stubbs B, Firth J, Berry A et al (2016) How much physical activity do people with schizophrenia engage in? A systematic review, comparative meta-analysis and meta-regression. Schizophr Res 176:431–440. https://doi.org/10.1016/j.schres.2016.05.017

    Article  PubMed  Google Scholar 

  5. Stubbs B, Vancampfort D, Hallgren M et al (2018) EPA guidance on physical activity as a treatment for severe mental illness: a meta-review of the evidence and Position Statement from the European Psychiatric Association (EPA), supported by the International Organization of Physical Therapists in Mental Health (IOPTMH). Eur Psychiatry 54:124–144. https://doi.org/10.1016/j.eurpsy.2018.07.004

    Article  PubMed  Google Scholar 

  6. Vancampfort D, Rosenbaum S, Ward PB, Stubbs B (2015) Exercise improves cardiorespiratory fitness in people with schizophrenia: a systematic review and meta-analysis. Schizophr Res 169:453–457. https://doi.org/10.1016/j.schres.2015.09.029

    Article  PubMed  Google Scholar 

  7. Pasquereau A, Andler R, Arwidson P, Nguyen-Thanh V (2020) Consommation de tabac parmi les adultes: bilan de cinq années de programme national contre le tabagisme, 2014–2019. Bull Epidémiol Hebd 14:273–281

    Google Scholar 

  8. Vancampfort D, Probst M, Scheewe T et al (2013) Relationships between physical fitness, physical activity, smoking and metabolic and mental health parameters in people with schizophrenia. Psychiatry Res 207:25–32. https://doi.org/10.1016/j.psychres.2012.09.026

    Article  PubMed  Google Scholar 

  9. Bobes J, Arango C, Garcia-Garcia M, Rejas J (2010) Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: an analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort. Schizophr Res 119:101–109. https://doi.org/10.1016/j.schres.2010.02.1030

    Article  PubMed  Google Scholar 

  10. Vancampfort D, Probst M, Sweers K et al (2011) Relationships between obesity, functional exercise capacity, physical activity participation and physical self-perception in people with schizophrenia. Acta Psychiatr Scand 123:423–430. https://doi.org/10.1111/j.1600-0447.2010.01666.x

    Article  CAS  PubMed  Google Scholar 

  11. Schoepf D, Uppal H, Potluri R, Heun R (2014) Physical comorbidity and its relevance on mortality in schizophrenia: a naturalistic 12-year follow-up in general hospital admissions. Eur Arch Psychiatry Clin Neurosci 264:3–28. https://doi.org/10.1007/s00406-013-0436-x

    Article  PubMed  Google Scholar 

  12. Vancampfort D, Stubbs B, Mitchell AJ et al (2015) Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis. World Psychiatry 14:339–347. https://doi.org/10.1002/wps.20252

    Article  PubMed  PubMed Central  Google Scholar 

  13. Bartels SJ, Pratt SI, Aschbrenner KA et al (2015) Pragmatic replication trial of health promotion coaching for obesity in serious mental illness and maintenance of outcomes. Am J Psychiatry 172:344–352. https://doi.org/10.1176/appi.ajp.2014.14030357

    Article  PubMed  Google Scholar 

  14. Bartels SJ, Pratt SI, Aschbrenner KA et al (2013) Clinically significant improved fitness and weight loss among overweight persons with serious mental illness. Psychiatr Serv 64:729–736. https://doi.org/10.1176/appi.ps.003622012

    Article  PubMed  PubMed Central  Google Scholar 

  15. Daumit GL, Dickerson FB, Wang N-Y et al (2013) A behavioral weight-loss intervention in persons with serious mental illness. N Engl J Med 368:1594–1602. https://doi.org/10.1056/NEJMoa1214530

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Erickson ZD, Mena SJ, Pierre JM et al (2016) Behavioral interventions for antipsychotic medication-associated obesity: a randomized, controlled clinical trial. J Clin Psychiatry 77:e183-189. https://doi.org/10.4088/JCP.14m09552

    Article  PubMed  Google Scholar 

  17. Brobakken MF, Nygård M, Güzey IC et al (2019) Aerobic interval training in standard treatment of out-patients with schizophrenia: a randomized controlled trial. Acta Psychiatr Scand 140:498–507. https://doi.org/10.1111/acps.13105

    Article  CAS  PubMed  Google Scholar 

  18. Poulin M-J, Chaput J-P, Simard V et al (2007) Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme. Aust N Z J Psychiatry 41:980–989. https://doi.org/10.1080/00048670701689428

    Article  PubMed  Google Scholar 

  19. Lee EE, Hong S, Martin AS et al (2017) Inflammation in schizophrenia: cytokine levels and their relationships to demographic and clinical variables. Am J Geriatr Psychiatry 25:50–61. https://doi.org/10.1016/j.jagp.2016.09.009

    Article  PubMed  Google Scholar 

  20. North HF, Bruggemann J, Cropley V et al (2021) Increased peripheral inflammation in schizophrenia is associated with worse cognitive performance and related cortical thickness reductions. Eur Arch Psychiatry Clin Neurosci 271:595–607. https://doi.org/10.1007/s00406-021-01237-z

    Article  PubMed  Google Scholar 

  21. Tsai S-Y, Sajatovic M, Hsu J-L et al (2020) Body mass index, residual psychotic symptoms, and inflammation associated with brain volume reduction in older patients with schizophrenia. Int J Geriatr Psychiatry 35:728–736. https://doi.org/10.1002/gps.5291

    Article  PubMed  Google Scholar 

  22. Hayashino Y, Jackson JL, Hirata T et al (2014) Effects of exercise on C-reactive protein, inflammatory cytokine and adipokine in patients with type 2 diabetes: a meta-analysis of randomized controlled trials. Metabolism 63:431–440. https://doi.org/10.1016/j.metabol.2013.08.018

    Article  CAS  PubMed  Google Scholar 

  23. Alizaei Yousefabadi H, Niyazi A, Alaee S et al (2021) Anti-inflammatory effects of exercise on metabolic syndrome patients: a systematic review and meta-analysis. Biol Res Nurs 23:280–292. https://doi.org/10.1177/1099800420958068

    Article  CAS  PubMed  Google Scholar 

  24. Martland R, Mondelli V, Gaughran F, Stubbs B (2020) Can high-intensity interval training improve physical and mental health outcomes? A meta-review of 33 systematic reviews across the lifespan. J Sports Sci 38:430–469. https://doi.org/10.1080/02640414.2019.1706829

    Article  PubMed  Google Scholar 

  25. Stubbs B, Gardner-Sood P, Smith S et al (2015) Sedentary behaviour is associated with elevated C-reactive protein levels in people with psychosis. Schizophr Res 168:461–464. https://doi.org/10.1016/j.schres.2015.07.003

    Article  PubMed  Google Scholar 

  26. Schürhoff F, Fond G, Berna F et al (2019) The 10-year findings from the FondaMental Academic Center of Expertise for Schizophrenia (FACE-SZ): review and recommendations for clinical practice. Encephale 45:9–14. https://doi.org/10.1016/j.encep.2018.07.007

    Article  PubMed  Google Scholar 

  27. Fond G, Godin O, Schürhoff F et al (2020) Confirmations, advances and recommendations for the daily care of schizophrenia based on the French national FACE-SZ cohort. Prog Neuropsychopharmacol Biol Psychiatry 101:109927. https://doi.org/10.1016/j.pnpbp.2020.109927

    Article  CAS  PubMed  Google Scholar 

  28. Schürhoff F, Fond G, Berna F et al (2015) A national network of schizophrenia expert centres: an innovative tool to bridge the research-practice gap. Eur Psychiatry. https://doi.org/10.1016/j.eurpsy.2015.05.004

    Article  PubMed  Google Scholar 

  29. Appelberg B, Tuisku K, Joffe G (2004) Is it worth while changing clinically stable schizophrenic out-patients with mild to moderate residual symptoms and/or side effects from conventional to atypical antipsychotics? A prospective, randomised study with olanzapine. Eur Psychiatry 19:516–518

    Article  Google Scholar 

  30. First MB, Spitzer RL, Gibbon M, Williams JBW (2002) Structured clinical interview for DSM-IV-TR axis I disorders, research version, patient edition (SCID-I/P). Biometrics research. New York State Psychiatric Institute, New York

    Google Scholar 

  31. Craig CL, Marshall AL, Sjöström M et al (2003) International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35:1381–1395. https://doi.org/10.1249/01.MSS.0000078924.61453.FB

    Article  PubMed  Google Scholar 

  32. World Health Organization: Geneva (2010) Global recommendations on physical activity for health. World Health Organization, Geneva

    Google Scholar 

  33. Wallwork RS, Fortgang R, Hashimoto R et al (2012) Searching for a consensus five-factor model of the Positive and Negative Syndrome Scale for schizophrenia. Schizophr Res 137:246–250. https://doi.org/10.1016/j.schres.2012.01.031

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Young RC, Biggs JT, Ziegler VE, Meyer DA (1978) A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133:429–435. https://doi.org/10.1192/bjp.133.5.429

    Article  CAS  PubMed  Google Scholar 

  35. Buysse DJ, Reynolds CF, Monk TH et al (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193–213. https://doi.org/10.1016/0165-1781(89)90047-4

    Article  CAS  PubMed  Google Scholar 

  36. Leucht S, Samara M, Heres S et al (2014) Dose equivalents for second-generation antipsychotics: the minimum effective dose method. Schizophr Bull 40:314–326. https://doi.org/10.1093/schbul/sbu001

    Article  PubMed  PubMed Central  Google Scholar 

  37. Misdrahi D, Tessier A, Swendsen J et al (2016) Determination of adherence profiles in schizophrenia using self-reported adherence: results from the FACE-SZ dataset. J Clin Psychiatry 77:e1130–e1136. https://doi.org/10.4088/JCP.15m10115

    Article  PubMed  Google Scholar 

  38. Fond G, Boyer L, Boucekine M et al (2017) Validation study of the Medication Adherence Rating Scale. Results from the FACE-SZ national dataset. Schizophr Res 182:84–89. https://doi.org/10.1016/j.schres.2016.10.023

    Article  PubMed  Google Scholar 

  39. Simpson GM, Angus JW (1970) A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 212:11–19. https://doi.org/10.1111/j.1600-0447.1970.tb02066.x

    Article  CAS  PubMed  Google Scholar 

  40. Barnes TR (1989) A rating scale for drug-induced akathisia. Br J Psychiatry 154:672–676. https://doi.org/10.1192/bjp.154.5.672

    Article  CAS  PubMed  Google Scholar 

  41. Boyer L, Simeoni M-C, Loundou A et al (2010) The development of the S-QoL 18: a shortened quality of life questionnaire for patients with schizophrenia. Schizophr Res 121:241–250. https://doi.org/10.1016/j.schres.2010.05.019

    Article  PubMed  Google Scholar 

  42. Morosini PL, Magliano L, Brambilla L et al (2000) Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning. Acta Psychiatr Scand 101:323–329

    Article  CAS  Google Scholar 

  43. Clayton AH, McGarvey EL, Clavet GJ (1997) The Changes in Sexual Functioning Questionnaire (CSFQ): development, reliability, and validity. Psychopharmacol Bull 33:731–745

    CAS  PubMed  Google Scholar 

  44. Fond G, Godin O, Dumontaud M et al (2019) Sexual dysfunctions are associated with major depression, chronic inflammation and anticholinergic consumption in the real-world schizophrenia FACE-SZ national cohort. Prog Neuropsychopharmacol Biol Psychiatry 94:109654. https://doi.org/10.1016/j.pnpbp.2019.109654

    Article  CAS  PubMed  Google Scholar 

  45. Battaglia G, Alesi M, Inguglia M et al (2013) Soccer practice as an add-on treatment in the management of individuals with a diagnosis of schizophrenia. Neuropsychiatr Dis Treat 9:595–603. https://doi.org/10.2147/NDT.S44066

    Article  PubMed  PubMed Central  Google Scholar 

  46. Dauwan M, Begemann MJH, Heringa SM, Sommer IE (2016) Exercise improves clinical symptoms, quality of life, global functioning, and depression in schizophrenia: a systematic review and meta-analysis. Schizophr Bull 42:588–599. https://doi.org/10.1093/schbul/sbv164

    Article  PubMed  Google Scholar 

  47. Fernández-Abascal B, Suárez-Pinilla P, Cobo-Corrales C et al (2021) In- and outpatient lifestyle interventions on diet and exercise and their effect on physical and psychological health: a systematic review and meta-analysis of randomised controlled trials in patients with schizophrenia spectrum disorders and first episode of psychosis. Neurosci Biobehav Rev 125:535–568. https://doi.org/10.1016/j.neubiorev.2021.01.005

    Article  PubMed  Google Scholar 

  48. Verdot C, Salanave B, Deschamps V (2020) Activité physique et sédentarité dans la population française. Situation en 2014–2016 et évolution depuis 2006–2007. Bull Epidémiol Hebd 15:296–304

    Google Scholar 

  49. Guthold R, Stevens GA, Riley LM, Bull FC (2018) Worldwide trends in insufficient physical activity from 2001 to 2016: a pooled analysis of 358 population-based surveys with 1·9 million participants. Lancet Glob Health 6:e1077–e1086. https://doi.org/10.1016/S2214-109X(18)30357-7

    Article  PubMed  Google Scholar 

  50. Roberts V, Maddison R, Simpson C et al (2012) The acute effects of exercise on cigarette cravings, withdrawal symptoms, affect, and smoking behaviour: systematic review update and meta-analysis. Psychopharmacology 222:1–15. https://doi.org/10.1007/s00213-012-2731-z

    Article  CAS  PubMed  Google Scholar 

  51. Taylor AH, Ussher MH, Faulkner G (2007) The acute effects of exercise on cigarette cravings, withdrawal symptoms, affect and smoking behaviour: a systematic review. Addiction 102:534–543. https://doi.org/10.1111/j.1360-0443.2006.01739.x

    Article  PubMed  Google Scholar 

  52. Espernberger KR, Fini NA, Peiris CL (2021) Personal and social factors that influence physical activity levels in community-dwelling stroke survivors: a systematic review of qualitative literature. Clin Rehabil 35:1044–1055. https://doi.org/10.1177/0269215521993690

    Article  PubMed  Google Scholar 

  53. Firth J, Cotter J, Elliott R et al (2015) A systematic review and meta-analysis of exercise interventions in schizophrenia patients. Psychol Med 45:1343–1361. https://doi.org/10.1017/S0033291714003110

    Article  CAS  PubMed  Google Scholar 

  54. Martin H, Beard S, Clissold N et al (2017) Combined aerobic and resistance exercise interventions for individuals with schizophrenia: a systematic review. Ment Health Phys Act 12:147–155. https://doi.org/10.1016/j.mhpa.2017.04.003

    Article  Google Scholar 

  55. Keller-Varady K, Varady PA, Röh A et al (2018) A systematic review of trials investigating strength training in schizophrenia spectrum disorders. Schizophr Res 192:64–68. https://doi.org/10.1016/j.schres.2017.06.008

    Article  PubMed  Google Scholar 

  56. Vancampfort D, Rosenbaum S, Schuch FB et al (2016) Prevalence and predictors of treatment dropout from physical activity interventions in schizophrenia: a meta-analysis. Gen Hosp Psychiatry 39:15–23. https://doi.org/10.1016/j.genhosppsych.2015.11.008

    Article  PubMed  Google Scholar 

  57. Bobes J, Alegría AA, Saiz-Gonzalez MD et al (2011) Change in psychiatrists’ attitudes towards the physical health care of patients with schizophrenia coinciding with the dissemination of the consensus on physical health in patients with schizophrenia. Eur Psychiatry 26:305–312. https://doi.org/10.1016/j.eurpsy.2010.04.004

    Article  CAS  PubMed  Google Scholar 

  58. Costa TB, Neri AL (2019) Associated factors with physical activity and social activity in a sample of Brazilian older adults: data from the FIBRA Study. Rev Bras Epidemiol 22:e190022. https://doi.org/10.1590/1980-549720190022

    Article  PubMed  Google Scholar 

  59. Eichinger M, Titze S, Haditsch B et al (2015) How are physical activity behaviors and cardiovascular risk factors associated with characteristics of the built and social residential environment? PLoS ONE 10:e0126010. https://doi.org/10.1371/journal.pone.0126010

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Flannery C, Dahly D, Byrne M et al (2019) Social, biological, behavioural and psychological factors related to physical activity during early pregnancy in the Screening for Pregnancy Endpoints (Cork, Ireland) cohort study. BMJ Open 9:e025003. https://doi.org/10.1136/bmjopen-2018-025003

    Article  PubMed  PubMed Central  Google Scholar 

  61. Morris KA, Arundell L, Cleland V, Teychenne M (2020) Social ecological factors associated with physical activity and screen time amongst mothers from disadvantaged neighbourhoods over three years. Int J Behav Nutr Phys Act 17:110. https://doi.org/10.1186/s12966-020-01015-5

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We would like to acknowledge the FondaMental foundation for their data providing.

Members of the FACE-SCZ Group: Andre Ma,f; Andrieu-Haller Ca,m; Aouizerate Ba,b, MD PhD; Berna Fa,c, MD PhD; Blanc Oa,d, Msc; Bourguignon Ea,e, Msc; Capdevielle Da,f, MD PhD; Chereau-Boudet Ia,d, MD; Clauss- Kobayashi Ja,c MD; Coulon Na,e,i, MD PhD; Dassing Ra,c, MSc; Dorey JMa,g, MD; Dubertret Ca,j, MD PhD; Esselin Aa,l, Msc; Fond Ga,m, MD; Gabayet Fa,i, Msc; Jarroir Ma,l, Msc; Lacelle Da,d, Msc; Leboyer Ma,e, MD PhD; Leignier Sa,i, MD; Llorca PMa,d, MD PhD; Mallet Ja,j, MD PhD; Metairie Ea,k, Msc; Michel Ta,f; Misdrahi Da,h, MD; Passerieux Ca,l, MD PhD; Petrucci Ja,e, Msc; Pignon Ba,e, MD; Peri Pa,k, Msc; Portalier Ca,j, Msc; Rey Ra,g, MD PhD; Roman Ca,i, Msc; Schorr Ba,c, MD; Schürhoff Fa,e, MD PhD; Szöke Aa,e, MD PhD; Tessier Aa,h, Msc; Urbach Ma,l, MD; Wachiche Ga,e, Msc; Zinetti-Bertschy Aa,c, Msc. a Fondation Fondamental; b University Department of General Psychiatry, Charles Perrens Hospital, F-33076 Bordeaux, France; Laboratory of Nutrition and Integrative Neurobiology (UMR INRA 1286), University of Bordeaux, France; c Strasbourg University Hospital, University of Strasbourg, INSERM U1114, Federation of Translational Psychiatry, Strasbourg, France; d Clermont-Ferrand University Hospital, rue montalembert, Clermont-Ferrand Cedex 1, France; e INSERM U955, Translational Psychiatry Team, DHU Pe PSY, Centre Expert Schizophrénie, Pôle de Psychiatrie et d’Addictologie des Hôpitaux Universitaires Henri Mondor, Paris Est University, 40 rue de Mesly, 94000 Créteil, France; f University Department of Adult Psychiatry, La Colombiere Hospital, CHU Montpellier, University of Montpellier 1, Inserm 1061, Montpellier, France; g INSERM, U1028; CNRS, UMR5292; University Lyon 1; Lyon Neuroscience Research Center, PSYR2 Team; le Vinatier Hospital, Schizophrenia Expert Centre, Lyon, F-69000, France; h University Department of General Psychiatry, Charles Perrens Hospital, F-33076 Bordeaux; University of Bordeaux, CNRS UMR 5287-INCIA, Bordeaux, France; i Schizophrenia Expert Center and Psychosocial Rehabilitation Reference Center, Alpes Isère Hospital, Grenoble, France; j AP-HP; Department of Psychiatry, Louis Mourier Hospital, Colombes, France; Inserm UMR1266, Institute of Psychiatry and Neuroscience of Paris, University Paris Descartes, France; Université Paris Diderot, Sorbonne Paris Cité, Faculté de médecine, France; k Department of Psychiatry (AP-HM), Sainte-Marguerite University Hospital, Marseille, France; l Versailles Hospital, Department of Adult Psychiatry and Addictology, Centre Hospitalier de Versailles, 177 rue de Versailles, 78157 Le Chesnay, France; DisAP-DevPsy-CESP, INSERM UMR1018, University of Paris-Saclay, University of Versailles Saint-Quentin-En-Yvelines 94807, Villejuif, France; m AP-HM, la Conception Hospital, Aix-Marseille Univ, School of medicine - La Timone Medical Campus, EA 3279: CEReSS - Health Service Research and Quality of Life Center, 27 Boulevard Jean Moulin, 13005 Marseille, France.

Funding

This work was funded by Hôpitaux Universitaires de Marseille (AP-HM).

Author information

Authors and Affiliations

  1. Fondation FondaMental, Créteil, France

    Pierre-Louis Sunhary De Verville, Damien Etchecopar-Etchart, Ophélia Godin, Christelle Andrieu-Haller, Fabrice Berna, Bruno Aouizerate, Delphine Capdevielle, Isabelle Chereau, Julie Clauss-Kobayashi, Nathalie Coulon, Jean-Michel Dorey, Caroline Dubertret, Sylvain Leignier, Jasmina Mallet, David Misdrahi, Catherine Passerieux, Baptiste Pignon, Romain Rey, Mathieu Urbach, Pierre-Michel Llorca, Franck Schürhoff, Christophe Lançon, Laurent Boyer & Guillaume Fond

  2. AP-HM, Aix-Marseille Univ, Faculté de Médecine-Secteur Timone, EA 3279: CEReSS-Centre d’Etude et de Recherche sur les Services de Santé et la Qualité de vie, 27 Boulevard Jean Moulin, 13005, Marseille, France

    Pierre-Louis Sunhary De Verville, Damien Etchecopar-Etchart, Christelle Andrieu-Haller, Christophe Lançon, Laurent Boyer & Guillaume Fond

  3. South London and Maudsley NHS Foundation Trust, Denmark Hill, London, SE5 8AZ, UK

    Brendon Stubbs

  4. Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King’s College London, London, UK

    Brendon Stubbs

  5. Université Paris Est Creteil (UPEC), AP-HP, Hôpitaux Universitaires “H. Mondor”, DMU IMPACT, INSERM, IMRB, Translational Neuropsychiatry, Fondation FondaMental, 94010, Creteil, France

    Ophélia Godin, Baptiste Pignon & Franck Schürhoff

  6. Hôpitaux Universitaires de Strasbourg, Université de Strasbourg, INSERM U1114, Fédération de Médecine Translationnelle de Strasbourg, Strasbourg, France

    Fabrice Berna & Julie Clauss-Kobayashi

  7. Pôle de Psychiatrie Générale Et Universitaire, Centre Hospitalier Charles Perrens, 33076 Université de Bordeaux, CNRS UMR 5287-INCIA, Bordeaux, France

    Bruno Aouizerate & David Misdrahi

  8. INRA, NutriNeuro, University of Bordeaux, U1286, 33076, Bordeaux, France

    Bruno Aouizerate

  9. Service Universitaire de Psychiatrie Adulte, Hôpital la Colombière, CHRU Montpellier, IGF, Univ. Montpellier, CNRS, INSERM, Montpellier, France

    Delphine Capdevielle

  10. Université Clermont Auvergne, CMP-B, CHU, CNRS, Clermont Auvergne INP, Institut Pascal, 63000, Clermont-Ferrand, France

    Isabelle Chereau & Pierre-Michel Llorca

  11. Centre Référent de Réhabilitation Psychosociale, CH Alpes Isère, Grenoble, France

    Nathalie Coulon & Sylvain Leignier

  12. INSERM U1028, CNRS UMR5292, Centre de Recherche en Neurosciences de Lyon, Université Claude Bernard Lyon 1, Equipe PSYR2, Centre Hospitalier Le Vinatier, Pole Est, 95 bd Pinel, BP 30039, 69678, Bron Cedex, France

    Jean-Michel Dorey & Romain Rey

  13. Department of Psychiatry, Université de Paris, AP-HP, Louis Mourier Hospital, Colombes, INSERM UMR 1266, Colombes, France

    Caroline Dubertret & Jasmina Mallet

  14. CNRS UMR 5287-INCIA, Paris, France

    David Misdrahi

  15. Service Universitaire de Psychiatrie d’Adultes et d’Addictologie, Centre Hospitalier de Versailles, 177 rue de Versailles, 78157, Le Chesnay, France

    Catherine Passerieux & Mathieu Urbach

  16. DisAP-DevPsy-CESP, INSERM UMR1018, Université Paris-Saclay, Université Versailles Saint-Quentin-En-Yvelines, 94807, Villejuif,, France

    Catherine Passerieux & Mathieu Urbach

Authors
  1. Pierre-Louis Sunhary De Verville
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Brendon Stubbs
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Damien Etchecopar-Etchart
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ophélia Godin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Christelle Andrieu-Haller
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Fabrice Berna
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Bruno Aouizerate
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Delphine Capdevielle
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Isabelle Chereau
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Julie Clauss-Kobayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Nathalie Coulon
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Jean-Michel Dorey
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Caroline Dubertret
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Sylvain Leignier
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Jasmina Mallet
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. David Misdrahi
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Catherine Passerieux
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Baptiste Pignon
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Romain Rey
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. Mathieu Urbach
    View author publications

    You can also search for this author in PubMed Google Scholar

  21. Pierre-Michel Llorca
    View author publications

    You can also search for this author in PubMed Google Scholar

  22. Franck Schürhoff
    View author publications

    You can also search for this author in PubMed Google Scholar

  23. Christophe Lançon
    View author publications

    You can also search for this author in PubMed Google Scholar

  24. Laurent Boyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  25. Guillaume Fond
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

Collaborators: the FACE-S. Z. (FondaMental Academic Centers of Expertise for Schizophrenia) Group

  • M. Andre
  • , C. Andrieu-Haller
  • , B. Aouizerate
  • , F. Berna
  • , O. Blanc
  • , E. Bourguignon
  • , D. Capdevielle
  • , I. Chereau-Boudet
  • , J. Clauss-Kobayashi
  • , N. Coulon
  • , R. Dassing
  • , J. M. Dorey
  • , C. Dubertret
  • , A. Esselin
  • , G. Fond
  • , F. Gabayet
  • , M. Jarroir
  • , D. Lacelle
  • , M. Leboyer
  • , S. Leignier
  • , P. M. Llorca
  • , J. Mallet
  • , E. Metairie
  • , T. Michel
  • , D. Misdrahi
  • , C. Passerieux
  • , J. Petrucci
  • , B. Pignon
  • , P. Peri
  • , C. Portalier
  • , R. Rey
  • , C. Roman
  • , B. Schorr
  • , F. Schürhoff
  • , A. Szöke
  • , A. Tessier
  • , M. Urbach
  • , G. Wachiche
  •  & A. Zinetti-Bertschy

Contributions

Concept and design: GF, LB. Interpretation of data: PLSdV, GF, LB. Drafting of the manuscript: PLSdV, GF, LB. Critical revision of the manuscript for important intellectual content: All the authors. Statistical analysis: LB, GF, PLSdV. Supervision: LB, GF.

Corresponding author

Correspondence to Guillaume Fond.

Ethics declarations

Conflict of interest

We declare no competing interests.

Additional information

The members of the FACE-SCZ Group are listed in Acknowledgements.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sunhary De Verville, PL., Stubbs, B., Etchecopar-Etchart, D. et al. Recommendations of the Schizophrenia Expert Center network for adequate physical activity in real-world schizophrenia (FACE-SZ). Eur Arch Psychiatry Clin Neurosci 272, 1273–1282 (2022). https://doi.org/10.1007/s00406-022-01384-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00406-022-01384-x

Keywords

Search

Navigation